AIM ImmunoTech Wins U.S. Patent for Ampligen Cancer Therapy
OCALA, Fla., August 31, 2026 AIM ImmunoTech Inc. announced that the U.S. Patent and Trademark Office (USPTO) has granted...
Patent
Advertisement
PharmAla Advances MDXX Manufacturing and Drug Pipeline
Toronto, Ontario, Canada, August 21, 2026 PharmAla Biotech Holdings Inc., a biotechnology company focused on the research, development, and...
Madrigal Pharmaceuticals Secures Three New Resmetirom U.S. Patents
CONSHOHOCKEN, Pa., July 13, 2026 Madrigal Pharmaceuticals announced that the U.S. Patent and Trademark Office (USPTO) has issued three...
Catheter Precision Wins Two Patents for VIVO and Cardionomix
FORT MILL, S.C., July 6, 2026 Catheter Precision, Inc. announced the issuance of two new patents covering key technologies...
Enveric Biosciences Gains U.S. Patent for EVM301
CAMBRIDGE, Mass., March 31, 2026 Enveric Biosciences has strengthened its position in the rapidly evolving neuropsychiatric drug development space...
Advertisement
